Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BioSure logo — BioSure provides rapid in-vitro diagnostic testing solutions...

BioSure

BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream.

Founded 2013 11-50 employees Non Equity Assistance Total: $905.00K Health Care, Manufacturing

General Information

Company Name BioSure
Founded Year 2013
Employees 11-50
Industries Health Care, Manufacturing
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with BioSure. To contact BioSure, visit hivselftest.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioSure compare?

A PDF of BioSure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioSure soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioSure

BioSure is a UK-based startup that is focused on providing rapid in-vitro diagnostic testing solutions. The company's slogan "BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream" encapsulates their mission to make diagnostic testing more accessible. Founded in 2013, BioSure is making strides in the Health Care and Manufacturing industries. The company is committed to expanding the use of rapid testing in healthcare and self-testing. Their goal is to change how disease diagnosis and drug detection are conducted in various settings, including personal, clinical, law enforcement, and commercial environments. Their dedication to making this technology accessible to everyone is evident in their efforts to make it cost-effective, straightforward, speedy, and accurate. In terms of support, BioSure received a Non-Equity Assistance investment from Pitch@Palace on November 7, 2018. This represents a vote of confidence from investors in the potential of BioSure's innovative approach to diagnostic testing. As the company continues to make advancements in the diagnostic testing space, it will be interesting to see how they utilize this support to further their impact in the healthcare and manufacturing industries.

Business keywords: In-vitro diagnostic testing, Point-of-care rapid tests, HIV self-test, Diagnostic testing solutions, Medical devices, Rapid testing, Self-testing, COVID-19 testing, Wellbeing, Preventative healthcare, Retail healthcare, Nasal spray, Clinical testing, Global healthcare

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Pitch@Palace
Pitch@Palace
07 Nov 2018
Series A £400.00K 1
VentureFounders
VentureFounders
31 Jan 2018
Series A £505.00K 1
VentureFounders
VentureFounders
30 Apr 2017

BioSure Alternatives & Competitors

View All Alternatives
BioSure vs
True Diagnostics™
True Diagnostics™ United States

FOR POINT OF CARE ANSWERS™

17 employees
Health Care, Manufacturing
BioSure vs
EKF Diagnostics
EKF Diagnostics United Kingdom

Point-of-care testing and life sciences applications that empower healthcare and non-medical provide...

Venture round
132 employees
Health Care, Manufacturing
BioSure vs
Verify Diagnostics
Verify Diagnostics Canada

Manufacturing and distributing high-quality rapid tests and in vitro diagnostic (IVD) devices.

17 employees
Health Care, Manufacturing
View all alternatives

FAQ About BioSure

BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream.
BioSure was founded in 2013.
BioSure operates in Health Care and Manufacturing. Its work centres on In-vitro diagnostic testing, Point-of-care rapid tests, HIV self-test and Diagnostic testing solutions.
BioSure has approximately 11-50 employees.
BioSure has completed 3 funding rounds, raising a total of $905.00K. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to BioSure include True Diagnostics™, EKF Diagnostics, Verify Diagnostics, Aidian, Surmodics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioSure and True Diagnostics™ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioSure, https://www.bouncewatch.com/company/biosure, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout